Stock Analysis

3 Growth Companies With High Insider Ownership And 132% Earnings Growth

SZSE:300499
Source: Shutterstock

As global markets navigate a landscape of easing inflation and strong bank earnings, major U.S. stock indexes have rebounded, with value stocks outperforming growth shares amid sector-specific shifts. In this context, identifying growth companies with high insider ownership can be particularly compelling, as such ownership often signals confidence in the company's future prospects and aligns management's interests with those of shareholders.

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
Clinuvel Pharmaceuticals (ASX:CUV)10.4%26.2%
SKS Technologies Group (ASX:SKS)29.7%24.8%
Propel Holdings (TSX:PRL)36.8%38.9%
CD Projekt (WSE:CDR)29.7%30.6%
Pharma Mar (BME:PHM)11.9%56.2%
Medley (TSE:4480)34%27.2%
On Holding (NYSE:ONON)19.1%29.7%
Brightstar Resources (ASX:BTR)16.2%84.3%
Elliptic Laboratories (OB:ELABS)26.8%121.1%
Findi (ASX:FND)35.8%110.9%

Click here to see the full list of 1467 stocks from our Fast Growing Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

Oscotec (KOSDAQ:A039200)

Simply Wall St Growth Rating: ★★★★★★

Overview: Oscotec Inc. is a biotechnology company involved in drug development, functional materials, and dental bone graft materials, with a market cap of ₩1.02 trillion.

Operations: The company generates revenue from several segments: ₩1.13 billion from the food business, ₩245.91 million from functional materials, ₩2.41 billion from the medical business sector, and ₩28.19 billion from the new drug business division.

Insider Ownership: 26.1%

Earnings Growth Forecast: 132.4% p.a.

Oscotec is positioned for significant growth, with revenue forecast to increase substantially faster than the South Korean market and expected profitability within three years. The company's earnings are projected to grow at a very high rate annually, supported by a strong return on equity forecast. Recent financial results highlight a turnaround from losses to notable profits, enhancing its appeal as it trades significantly below estimated fair value. No substantial insider transactions have been reported recently.

KOSDAQ:A039200 Ownership Breakdown as at Jan 2025
KOSDAQ:A039200 Ownership Breakdown as at Jan 2025

i-SENS (KOSDAQ:A099190)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: i-SENS, Inc. develops, manufactures, and sells chemical and biosensors in South Korea and internationally with a market cap of ₩507.43 billion.

Operations: The company's revenue primarily comes from its Diagnostic Kits / Equipment segment, generating ₩284.77 million.

Insider Ownership: 25%

Earnings Growth Forecast: 62.1% p.a.

i-SENS is forecasted to achieve profitability within three years, with revenue growth projected at 18.1% annually, surpassing the South Korean market average. The company's recent financial results show a turnaround from a net loss to a modest profit in the third quarter. Despite its low future return on equity of 2.9%, i-SENS trades at an attractive valuation relative to industry peers, although no significant insider trading activity has been reported recently.

KOSDAQ:A099190 Earnings and Revenue Growth as at Jan 2025
KOSDAQ:A099190 Earnings and Revenue Growth as at Jan 2025

Guangzhou Goaland Energy Conservation Tech (SZSE:300499)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Guangzhou Goaland Energy Conservation Tech (SZSE:300499) specializes in energy conservation technologies and has a market cap of CN¥6.22 billion.

Operations: Revenue Segments (in millions of CN¥):

Insider Ownership: 21.2%

Earnings Growth Forecast: 83% p.a.

Guangzhou Goaland Energy Conservation Tech is forecasted to achieve profitability in the next three years, with revenue growth projected at 34.9% annually, outpacing the Chinese market average. Despite a recent net loss of CNY 17.65 million for the nine months ending September 2024, earnings are expected to grow significantly at 82.96% per year. However, its return on equity is anticipated to remain low at 6.6%, and no significant insider trading activity has been reported recently.

SZSE:300499 Earnings and Revenue Growth as at Jan 2025
SZSE:300499 Earnings and Revenue Growth as at Jan 2025

Summing It All Up

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com